APOE and Alzheimer disease: Doconexent is an omega 3 fatty acid used as nutritional supplement that has been tested in a randomized clinical trial for its ability to slow the rate of cognitive and functional decline in the general population of AD patients (NCT0044005051) and in APOE4 allele carriers (NCT0361384452).